PharmaSGP lifts forecasts following GSK deal

20 September 2021 - Deborah Wilkes

Premium

PharmaSGP has raised its financial forecasts for 2021 following the acquisition of a portfolio of four OTC brands from GlaxoSmithKline (GSK). The news came as the German consumer healthcare company reported sales down by a fifth in the first half of 2021.

Click tags below for more information on topics:

PharmaSGP

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: